Lavipharm Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.11	5.59	8.44	18.24	1.64
Short-Term Investments	-	-	-	-	0
Trading Asset Securities	-	-	0	0	-
Cash & Short-Term Investments	6.11	5.59	8.44	18.24	1.64
Cash Growth	9.25%	-33.76%	-53.75%	1013.12%	-15.99%
Accounts Receivable	19.03	12.42	12.17	8.68	7.58
Other Receivables	3.6	3.72	2.85	5.2	5.33
Receivables	22.63	16.14	16.57	15.43	14.45
Inventory	22.94	20.49	16.21	10.44	9.24
Prepaid Expenses	1.22	0.86	1.38	-	-
Other Current Assets	0.3	1.92	3.06	1.49	0.64
Total Current Assets	53.2	45	45.65	45.6	25.96
Property, Plant & Equipment	21.97	21.36	19.54	17.06	17.46
Long-Term Investments	0.2	0	1.05	0.52	-
Other Intangible Assets	41.84	45.18	41.04	44.02	1.31
Long-Term Deferred Tax Assets	4.94	6.55	1.25	2.37	3.06
Long-Term Deferred Charges	7.09	4.5	3.5	2.18	1.83
Other Long-Term Assets	1	2.9	2.75	2.42	3.12
Total Assets	130.22	125.48	114.79	114.17	52.74
Accounts Payable	9.68	8.18	8.03	6.3	4.16
Accrued Expenses	4	2.81	3.06	6.65	4.46
Short-Term Debt	9.1	9.24	6.59	21.71	21.4
Current Portion of Long-Term Debt	1.43	1.43	1.51	-	-
Current Portion of Leases	1.42	0.91	0.68	0.52	0.66
Current Income Taxes Payable	0.54	0.25	0.24	0.51	0.1
Current Unearned Revenue	0.38	0.47	0.51	0.42	0.42
Other Current Liabilities	17.43	15.85	15.17	9.63	9.87
Total Current Liabilities	43.98	39.13	35.8	45.74	41.07
Long-Term Debt	10.22	12.17	12.7	3.96	4
Long-Term Leases	10.61	10.17	11	10.99	11.28
Pension & Post-Retirement Benefits	1.08	0.95	1.08	0.94	1.09
Other Long-Term Liabilities	7.92	10.1	11.44	12.23	5.25
Total Liabilities	73.81	72.52	72.02	73.86	62.68
Common Stock	50.71	50.61	50.36	50.36	51.08
Additional Paid-In Capital	7.06	7.17	7.41	7.41	84.42
Retained Earnings	-18.74	-21.35	-30.24	-32.11	-159.96
Comprehensive Income & Other	17.38	16.56	15.21	14.62	14.48
Total Common Equity	56.42	52.98	42.74	40.28	-9.98
Minority Interest	-0.01	-0.01	0.03	0.04	0.04
Shareholders' Equity	56.41	52.97	42.77	40.31	-9.94
Total Liabilities & Equity	130.22	125.48	114.79	114.17	52.74
Total Debt	32.78	33.92	32.48	37.18	37.33
Net Cash (Debt)	-26.67	-28.34	-24.04	-18.93	-35.69
Net Cash Per Share	-0.16	-0.17	-0.14	-0.88	-2.10
Filing Date Shares Outstanding	169.04	168.69	167.87	167.87	17.03
Total Common Shares Outstanding	169.04	168.69	167.87	167.87	17.03
Working Capital	9.22	5.88	9.85	-0.14	-15.11
Book Value Per Share	0.33	0.31	0.25	0.24	-0.59
Tangible Book Value	14.59	7.79	1.69	-3.74	-11.29
Tangible Book Value Per Share	0.09	0.05	0.01	-0.02	-0.66
Land	1.93	1.93	1.93	1.93	1.93
Buildings	3.2	2.72	1.74	1.53	1.49
Machinery	22.5	21.45	21.14	19.31	19.09

Source: S&P Global Market Intelligence. Standard template. Financial Sources.